Hanmei Xu

机构：China Pharmaceutical University · ORCID：0000-0002-8942-0794

发表论文 48 篇 · 总被引 2396 次 · h-index 21

代表论文

Trends in insulin resistance: insights into mechanisms and therapeutic strategy (2022 · Signal Transduction and Targeted Therapy · 被引 892)
NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice (2020 · Journal of Neuroinflammation · 被引 166)
Nucleic acid drugs: recent progress and future perspectives (2024 · Signal Transduction and Targeted Therapy · 被引 163)
Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes (2021 · Signal Transduction and Targeted Therapy · 被引 96)
Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas (2020 · Cell Death and Disease · 被引 81)
Potential therapeutic applications of exosomes in different autoimmune diseases (2019 · Clinical Immunology · 被引 78)